|Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy|
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
|Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis|
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
|Efficient periodicity mining in time series databases using suffix trees|
F Rasheed, M Alshalalfa, R Alhajj
IEEE Transactions on Knowledge and Data Engineering 23 (1), 79-94, 2010
|Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes|
SA Tomlins, M Alshalalfa, E Davicioni, N Erho, K Yousefi, S Zhao, ...
European urology 68 (4), 555-567, 2015
|The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer|
JR Prensner, A Sahu, MK Iyer, R Malik, B Chandler, IA Asangani, ...
Oncotarget 5 (6), 1434, 2014
|Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome|
S You, BS Knudsen, N Erho, M Alshalalfa, M Takhar, HA Ashab, ...
Cancer research 76 (17), 4948-4958, 2016
|Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies|
R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ...
Oncotarget 7 (33), 53362, 2016
|Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis|
B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ...
Prostate cancer and prostatic diseases 20 (1), 28-35, 2017
|Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer|
A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen, IM Coleman, D Vodák, ...
Cell reports 19 (10), 2045-2059, 2017
|Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer|
L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ...
EBioMedicine 31, 182-189, 2018
|Racial variations in prostate cancer molecular subtypes and androgen receptor signaling reflect anatomic tumor location|
FA Faisal, D Sundi, JJ Tosoian, V Choeurng, M Alshalalfa, AE Ross, ...
European urology 70 (1), 14-17, 2016
|TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup|
DP Labbé, CJ Sweeney, M Brown, P Galbo, S Rosario, KM Wadosky, ...
Clinical Cancer Research 23 (22), 7072-7083, 2017
|Clinical and genomic characterization of low–prostate-specific antigen, high-grade prostate cancer|
BA Mahal, DD Yang, NQ Wang, M Alshalalfa, E Davicioni, V Choeurng, ...
European urology 74 (2), 146-154, 2018
|Application of a clinical whole-transcriptome assay for staging and prognosis of prostate cancer diagnosed in needle core biopsy specimens|
BS Knudsen, HL Kim, N Erho, H Shin, M Alshalalfa, LLC Lam, I Tenggara, ...
The Journal of Molecular Diagnostics 18 (3), 395-406, 2016
|Multi-institutional analysis shows that low PCAT-14 expression associates with poor outcomes in prostate cancer|
NM White, SG Zhao, J Zhang, EB Rozycki, HX Dang, SD McFadden, ...
European urology 71 (2), 257-266, 2017
|Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer|
AP Mitra, LL Lam, M Ghadessi, N Erho, IA Vergara, M Alshalalfa, C Buerki, ...
JNCI: Journal of the National Cancer Institute 106 (11), 2014
|Cyclin D1 loss distinguishes prostatic small-cell carcinoma from most prostatic adenocarcinomas|
H Tsai, CL Morais, M Alshalalfa, HL Tan, Z Haddad, J Hicks, N Gupta, ...
Clinical Cancer Research 21 (24), 5619-5629, 2015
|Molecular characterization of neuroendocrine-like bladder cancer|
JB Da Costa, EA Gibb, TJ Bivalacqua, Y Liu, HZ Oo, DT Miyamoto, ...
Clinical cancer research 25 (13), 3908-3920, 2019
|The DNA methylation landscape of advanced prostate cancer|
SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ...
Nature genetics 52 (8), 778-789, 2020
|The diverse genomic landscape of clinically low-risk prostate cancer|
MR Cooperberg, N Erho, JM Chan, FY Feng, N Fishbane, SG Zhao, ...
European urology 74 (4), 444-452, 2018